Older people ‘bombarded' with ads for funerals, care homes and mobility aids

Older people say they are being 'bombarded' by campaigns for funeral services, care homes and mobility aids by 'out-of-touch' mainstream advertising, a study has found.
The Advertising Standards Authority (ASA) said more than a third of the UK population (35%) agreed that older people tended to be negatively stereotyped in ads, with other depictions such as forgetfulness, frailty or not being able to use technology also seen as potentially offensive.
While not offensive, depictions such as older people always being wealthy or grumpy, or ads that showed them doing extreme and unrealistic activities, were found to be cliched and irritating.
Almost half (49%) said ads using humour at the expense of older people were likely to cause offence.
Some 44% believed that older people were either underrepresented or not represented at all in ads, particularly in categories like fashion, beauty, technology and household goods.
Respondents also raised concerns about how ads were targeted, saying they felt 'bombarded' by promotions for end-of-life services such as funerals or cremations, life insurance and care homes.
The ASA's report, based on focus groups and a survey of 4,000 UK adults, said older people were not only living longer but also continuing to lead full, active lives, contributing to workplaces, families, communities and the economy for longer.
However, many of those surveyed said that advertising too often painted a 'very different and outdated picture'.
The watchdog said ads showing older people as lonely, purposeless or powerless could be harmful – especially for those aged 75 and over, for whom these portrayals reinforced fears about ageing and social isolation.
It also flagged beauty ads that suggested ageing must be 'fought' as potentially harmful.
In particular, women aged 65 and over recognised the potential for these ads to cause harm to the self-esteem of women of all ages.
The ASA said the findings suggested the ad industry may be 'out of touch' with the reality of ageing.
Instead, the public wanted advertising to focus on individuals rather than their age, and portray a diverse range of later-life experiences.
The ASA said: 'When ads show older people as vibrant, capable and real, they help rewrite the story of ageing and how we perceive older generations.
'Not only this, but older people represent a significant market with substantial spending power, making them a vital audience for brands that want to stay relevant.
'While we're not currently proposing any new rules, we're hoping that by sharing this research, advertisers will understand how some portrayals of older people are landing with the public today – and where there may be unintended consequences.'
Kam Atwal, research lead at the ASA, said: 'As a society, we're living longer, richer and more varied lives.
'Our research reveals that some of today's portrayals of older people in advertising are not being received positively, and that the public want ads to better reflect the varied lives older people lead today.
'This is a real opportunity for brands to embrace the true diversity of later life and take a leading role in challenging outdated perceptions.'
Harriet Bailiss, co-head of the Age Without Limits campaign, run by the Centre for Ageing Better charity, said: 'We really welcome this excellent report from the ASA.
'We live in a society where ageism is the most common form of discrimination. We should all want that to end and we all have a role to play in making that happen.
'Advertising has such a powerful influence on society and can help bring about that change and be a force for good, as it has already been for changing other outdated perceptions.'

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

The Independent

an hour ago

• The Independent

How long will you live? This exercise test may have the answer

A new study has shown how a simple exercise could predict natural and cardiovascular causes of death. Researchers wanted to see whether non-aerobic physical fitness, assessed by a sitting-rising test, could predict premature deaths in middle-aged and older people, and on Wednesday, their results were published in the European Journal of Preventive Cardiology. They tested the theory on 4,282 adults aged 46-75 years from 1998 to 2023. Most of the participants, 68 percent, were men. 'None of them presented relevant physical or clinical limitations for fitness testing,' researchers said. All of the participants performed a sitting-rising test to evaluate the main components of non-aerobic physical fitness, which are muscle strength/power, flexibility, balance and body composition. The test was simple, yet not necessarily easy. Participants had to sit and rise from the floor without other body parts such as hands, elbows or knees touching the floor. Their instructions were as follows: ''Without worrying about the speed of movement, try to sit and then rise from the floor, using the minimum support that you believe is needed,'' the study's authors wrote. If participants used any extremities for support, they'd lose points. They also needed to steady themselves as a perceived partial loss of balance would knock down their score. Researchers found that non-aerobic physical fitness 'was a significant predictor' of natural and cardiovascular mortality in the participants. After following up with patients about 12 years later, researchers found there were 665 deaths due to natural causes. Those who scored a perfect 10 points on the sitting-rising test had death rates of 3.7 percent. Death rates tripled to 11.1 percent for people with a score of 8 points and 'dramatically increased' by 42.1 percent for those with a score of 0 to 4 points, according to researchers. The study was done at a private clinic in Rio de Janeiro, Brazil, and most of the participants 'belonged to upper socioeconomic and education strata of the country.'

Times

3 hours ago

• Times

Simple blood test could provide first reliable diagnosis for ME

Scientists have found biological signatures in the blood of people with myalgic encephalomyelitis (ME), a breakthrough that could lead to the first reliable test for the debilitating condition. ME, also known as chronic fatigue syndrome (CFS), affects an estimated 400,000 people in the UK. Symptoms can include pain, brain fog and extremely low energy levels that do not improve with rest. These often become dramatically worse after even minor physical effort, a phenomenon known as post-exertional malaise. There is no cure and the cause is unknown. A diagnosis is typically made by ­ruling out other illnesses, a process that can take years. The new study, led by ­researchers from Edinburgh University, may mark a turning point. Using data from the UK Biobank, they compared blood samples from 1,455 ME patients with those of more than 131,000 healthy people and identified dozens of molecules that ­differed in concentrations between the two, as well as different cell counts. The changes in the ME patients, who all had mild to moderate forms of the disease, were largely related to chronic inflammation, insulin resistance and liver dysfunction. The findings were replicated in a group of American patients and healthy controls. Professor Chris Ponting, of the university's Institute of Genetics and Cancer, said: 'For so long people with ME/CFS have been told it's all in their head. It's not. We see [it] in their blood. 'Evidence of a large number of replicated and diverse blood biomarkers that differentiate between ME/CFS cases and controls should dispel any lingering perception it is caused by deconditioning and exercise intolerance.' The study found 116 'biomarkers' for ME in the blood of men and women with the condition — a key finding, because ME can affect the sexes differently. These markers did not change according to how active the patients were, consistent with the view that graded exercise therapy, which aims to gradually increase activity levels, is unlikely to be helpful. The strongest differences were found in people who reported post-exertional malaise, which may underscore its central role in the illness. Dr Sjoerd Beentjes, of the university's School of Mathematics, said: 'Blood differences are sometimes attributed to reduced activity levels rather than ME/CFS directly. Our study provides strong evidence ME/CFS affects blood traits through paths other than activity.' The authors stressed that the research was at an early stage with no guarantees a test would be possible. The government pledged last year to improve ME research and the NHS agreed to assess services for patients across England after an inquest into the death at 27 of Maeve Boothby O'Neill in 2021. She had suffered from ME since she was a teenager. The daughter of Sarah Boothby and Sean O'Neill, a senior journalist at The Times, she was left bedbound, unable to speak and malnourished. The coroner issued a prevention of future deaths report in October, the first of its kind for ME, and urged Wes Streeting, the health secretary, NHS officials and health bodies to take action to address the 'non-existent' care and lack of funding for research.

Times

3 hours ago

• Times

Last chance for MPs to think again on assisted dying

The assisted dying bill has split voters and MPs TOLGA AKMEN/EPA I n November, when the assisted dying bill had its second reading in the House of Commons, its sponsor Kim Leadbeater reassured fellow MPs that a vote in favour was only 'to continue the debate' and ' to subject the bill to line-by-line scrutiny'. That conversation ­— which permitted wavering MPs to interrogate their decision further ­— is drawing to a close. Today, MPs will vote on the third and final reading of the bill, after which it could go to the House of Lords. What has emerged from that 'line-by-line scrutiny', however, has chilled many legislators and observers to the core. Firstly, there is the nature of the scrutiny itself. Because this was not a government bill, but a private member's one, Ms Leadbeater was able to handpick the committee and exercise control over the witnesses called. It did not boost confidence in an impartial process. Indeed, four Labour MPs raised concerns that the committee's evidence was 'weighted towards those who were known to be supportive of the bill'. Of eight witnesses called from foreign jurisdictions with an assisted dying law, for example, not one was critical of how the legislation had played out — despite there being numerous experts with misgivings, such as Theo Boer of the Dutch Health Council. Formerly pro-euthanasia, he became horrified by the steady expansion of the system and its eligibility from what was first intended. Although the UK bill is being sold on the basis that it is strictly limited to those with a terminal diagnosis of less than six months, Mr Boer has warned that 'our safeguards were presented that way too.' In the Netherlands, assisted dying provision now includes children over 12 years old and those with psychiatric disorders. If the passage of this bill has been distinguished by procedural ruthlessness, that has been matched only by its intellectual woolliness. The absence of tight, ethical safeguards to protect the vulnerable — in particular those with mental health problems — has caused deep anxiety in ­organisations at the sharp end of patient care: the Royal College of Psychiatrists, the Association for Palliative Medicine, and the Royal College of ­Physicians have all raised serious concerns. Tellingly, the two ministers whose departments would be most involved in the bill's implementation, the health secretary Wes Streeting and the justice secretary Shabana Mahmood, are both opposed. Many safeguarding amendments have been shrugged aside. MPs who vote yes on Friday will be voting to permit doctors to raise the subject of ending a patient's life, including with people who have learning disabilities. The door is open for private contractors to get involved in running the service with no transparency obligations or cap on profits. And as the former prime minister Gordon Brown argues, the legal right to assisted dying would not be matched by any equivalent right to high-quality palliative care, making a cruel nonsense of real choice for many of those in extremis. Sir Keir Starmer has repeated his support for the principle of the bill, while distancing himself from the legislation. But should its proposals take full effect in 2029 as stipulated, close to the next general election, troubled voters who consider it a deal-breaker will inevitably connect it to the prime minister. There are many others, too, who back assisted dying in good faith, but this flawed bill delivers a far greater number of dangers than it does solutions. Before it is too late, its parliamentary supporters can, and must, think again.